ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

GWP GW Pharm.

735.00
0.00 (0.00%)
16 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
GW Pharm. LSE:GWP London Ordinary Share GB0030544687 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 735.00 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Appointment

16/04/2003 8:02am

UK Regulatory


RNS Number:0908K
GW Pharmaceuticals PLC
16 April 2003


For Immediate Release                                           16 April 2003

                             GW Pharmaceuticals plc
                                        
                            ("GW" or "the Company")

                      Appointment of Non-Executive Director
                                        
GW announces the appointment of Hans Schram as a non-executive director with
immediate effect. Mr Schram has over 20 years experience in global
pharmaceutical business development and marketing.

Mr Schram is currently Chief Executive Officer of Nordic Group, a specialist
pharmaceutical sales and marketing company with operations in Scandinavia, UK,
Netherlands and France. Prior to this appointment he spent 18 years at Ferring
Group, an international pharmaceutical company operating in over 40 countries
with annual revenues of over Euro 500 million. Mr Schram was a member of
Ferring's Executive Management Team and Senior Vice President, International
Business Development. Mr Schram also held posts as Managing Director of several
of the European affiliates and as Regional Director of the Group's operations in
Asia, Central & Eastern Europe, Latin America, and Middle East.

Prior to Ferring, Mr Schram was at Ciba Geigy in Switzerland and at Pierre Fabre
Laboratories, the French phytomedicines company, responsible for pharmaceutical
operations in Northern Europe, North America, South East Asia and Japan.

Dr Geoffrey Guy, Executive Chairman, said, "Mr Schram is a seasoned
pharmaceutical executive with international commercial expertise whom I am
delighted to welcome to the Board. He brings to GW a wealth of experience in
managing commercial relationships as well as marketing pharmaceutical products
across all regions of the world."

Enquiries:

GW Pharmaceuticals plc                                 (15/04/03) 020 7067 0700
Dr Geoffrey Guy, Chairman                              (Thereafter)01980 557000
Justin Gover, Managing Director

Weber Shandwick Square Mile                                       020 7067 0700
Kevin Smith/Graham Herring


Appendix

HANS SCHRAM - LIST OF CURRENT AND FORMER DIRECTORSHIPS

Former directorships held since 1 April 1998:

Ferring Australia Ltd                              Australia
Ferring Pharmaceuticals Ltd                        Israel
Ferring Pharmaceuticals Ltd                        Hong Kong
Ferring Yak Pum Yuhan Hoesa                        Korea
Ferring Pharmaceuticals Ltd (Taiwan)               Taiwan
Ferring SA                                         Argentina
Ferring Pharmaceuticals BV                         Netherlands
Ferring Product Development BV                     Netherlands
Ferring Pharmaceuticals (China) Co. Ltd            China
Ferring Sa de CV                                   Mexico
Ferring (Proprietary) Ltd                          South Africa

Current directorships:

QPharma AB                                         Sweden
Nordic Drugs AB                                    Sweden
Nordic Pharma Ltd                                  UK
Nordic Geneesmiddelen BV                           Netherlands
Ferring Leciva AS                                  Czech Rep.

There are no further disclosures to be made in respect of Hans Schram pursuant
to paragraph (f) of Schedule 2 of the AiM Rules for companies.







                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
BOAEAELSFEADEAE

1 Year Gw Pharmaceuticals Chart

1 Year Gw Pharmaceuticals Chart

1 Month Gw Pharmaceuticals Chart

1 Month Gw Pharmaceuticals Chart